Ascendis Pharma Employee Warrant Grants and Articles Amendment

Ascendis Pharma A/S filed a Form 6-K reporting that on March 10, 2026, the company's board of directors granted 22,480 warrants to certain employees under the terms of Appendix 1a to the company's Articles of Association. The company also amended its Articles of Association to provide for these warrant grants. Each warrant confers the right to subscribe for one ordinary share at an exercise price of $240.52 per share, which equals the closing price of the company's American Depositary Shares on the grant date. The warrants vest with 25% vesting on the one-year anniversary of the grant date and the remaining 75% vesting monthly over the subsequent 36 months, subject to continued service. After this grant, warrants for an additional 1,644,153 shares remain available for future grants. The filing includes the full Articles of Association as an exhibit and notes that the Form 6-K is incorporated by reference into various registration statements.